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Introduction
Gastrointestinal stromal tumors (GISTs) occur most fre-
quently in the stomach.1-4 Wedge resection of the stomach with 
R0 resection is regarded as a standard treatment because of the 
low risk of lymph node metastasis from the tumor.2,5-7 Relatively 
small sized tumors have been safely treated by various laparo-
scopic approaches since the first report of laparoscopic wedge 
resection (LWR) of a gastric submucosal tumor in 1991.8-11 
Although laparoscopic gastric wedge resection for extralumi-
nal tumors can be performed easily, intraluminal or small tumors 
are difficult to localize laparoscopically, requiring an intragastric 
approach or gastrotomy for tumor resection.12-16 Consequently, 
the possibility of spreading cancer cells in the abdominal cav-
ity arises due to the additional manipulation of the tumor and 
luminal exposure during these procedures. Thus, it could be a 
risk factor for peritoneal recurrence. In addition, if the tumors 
have ulcerations, the risk of cancer cell dissemination might in-
crease.17,18 
So far, there is no report regarding the long-term outcomes 
of laparoscopic gastric wedge resection with gastrotomy for the 
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Purpose: Various laparoscopic wedge resection (LWR) techniques requiring gastrotomy for gastrointestinal stromal tumors (GISTs) of 
the stomach have been applied to facilitate tumor resection and preserve the remnant gastric volume. However, there is the possibility 
of cancer cell dissemination during these procedures. The aim of this study was to assess the oncologic safety of LWR with gastrotomy 
(LWR-G) compared to LWR without luminal exposure.
Materials and Methods: Clinicopathologic and operative results of 193 patients who underwent LWR for gastric GIST were retrospec-
tively analyzed from 2003 to 2013. We stratified the patients into two groups: LWR-G and LWR without gastrotomy (LWR-C). Clinico-
pathologic features, short-term outcomes, and long-term outcomes were compared. 
Results: A total of 26 patients underwent LWR-G, and 167 patients underwent LWR-C. The LWR-G group showed significantly more an-
terior wall-located (n=10, 38.5%), intraluminal (n=20, 76.9%), and ulcerative (n=13, 50.0%) tumors than the LWR-C group (n=33, 
19.8%; n=96, 57.5%; n=46, 27.5%, respectively). Postoperative short-term outcomes did not differ between the two groups. When 
tumor staging was compared, no statistical difference was noted. There was no recurrence in the LWR-G group, while 2 patients in the 
LWR-C group experienced recurrence. The two recurrences in the LWR-C group were found in the liver and in the remnant stomach at 
63 and 12 months after the operation, respectively. No gastric GIST-related death was recorded in any group during the study period.
Conclusions: LWR-G for gastric GIST is an oncologically safe procedure even for masses with ulcerations. 
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treatment of gastric GISTs. In the current study, we compared 
the oncologic safety of LWR with gastrotomy (LWR-G) and 
LWR without luminal exposure. Specifically, the long-term 
consequences for ulcerative GISTs requiring luminal exposure 
during operation were investigated. Recurrence patterns were 
also analyzed.
Materials and Methods
1. Patients
Between March 2003 and December 2013, 205 LWRs of the 
stomach were performed in patients with histologically con-
firmed gastric GISTs at the Department of Surgery at Yonsei 
University College of Medicine. The study included 193 patients 
who underwent LWR of the stomach. Of the 193 patients, 26 
underwent LWR-G, while the other 167 underwent LWR with-
out gastrotomy (LWR-C). Patients were excluded if they had a 
ruptured tumor at the time of diagnosis, underwent palliative re-
section or an endoscopic procedure before the operation, or had 
insufficient data regarding mitotic rate for proper staging (Fig. 1). 
On the basis of preoperative endoscopy, endoscopic ultrasound, 
and abdominopelvic computed tomography scanning, LWR 
was generally indicated for relatively small gastric submucosal 
tumors up to 5 cm in the early period, and later on, the indica-
tion was expanded to include tumors larger than 5 cm. The type 
of resection was selected at the surgeon’s discretion according 
to the tumor location and size. Patients who were pathologically 
classified as high risk according to the National Institutes of 
Health-Fletcher classification were recommended for treatment 
with imatinib mesylate (Gleevec®; Novartis, Basel, Switzerland), 
whenever possible. Clinicopathologic characteristics, short-term 
outcomes, and long-term outcomes, including recurrence and 
survival status, were analyzed retrospectively.
This retrospective study to compare outcomes with another 
surgical techniques was approved by the Institutional Review 
Board (IRB) of Severance Hospital, Yonsei University College 
of Medicine (4-2015-0865).
2. Surgical technique
Various laparoscopic gastric wedge resection techniques have 
been described in the literature.1,5,12,13,15,18 When tumors grow 
outward from the stomach toward the peritoneal cavity, wedge 
resection using endolinear staplers can be performed easily 
without considerable manipulation of the tumor.12-14 In cases of 
intraluminal tumors in the posterior wall of the stomach, trans-
gastric tumor-everting methods followed by gastrotomy of the 
anterior wall of the stomach facilitate tumor resection.13,14,19,20 
When performing this procedure, the lesion was identified by 
endoscopy or laparoscopic ultrasonography, and the optimal site 
of the anterior stomach wall for gastrotomy was chosen. After 
an incision was made, the tumor was removed by transecting the 
inverted posterior wall using endolinear staplers. The anterior 
wall was closed with endolinear staplers or with a laparoscopic 
suture technique.14,19 When relatively larger intraluminal tumors 
are located in the anterior wall, the eversion method can fa-
cilitate tumor resection and minimize excessive resection of the 
normal gastric wall.15 For this procedure, a gastrotomy was cre-
ated about 1 cm from the tumor margin by using intraoperative 
laparoscopic ultrasonography. Then, the tumor was exteriorized 
via the incision and resected by endolinear staplers. The advan-
tage of this procedure was that the gastrotomy was closed at the 
same time the endolinear staplers were applied.15 For intralu-
minal tumors near the cardia or the pylorus, the preferred pro-
cedure may be intragastric wedge resection with single incision 
intragastric or conventional intragastric procedures to minimize 
deformity of the esophagogastric junction or the pylorus.18,21-23 
For the single incision intragastric procedure, two wound pro-
tectors were used. The anterior gastrotomy was made and pulled 
out of the abdominal incision, and then another wound protector 
205 patients underwent laparoscopic wedge
resection for gastric GIST
202
3 with ruptured tumor at diagnosis
or during endoscopic diagnosis
200
2 underwent palliative
(R1) resection
199
1 with preoperative endoscopic
submucosal dissection
193
6 with insufficient data
of mitotic rate
LWR-C
(n=26)
LWR-C
(n=167)
Fig. 1. Patient disposition. GIST = gastrointestinal stromal tumor; 
LWR-G = laparoscopic wedge resection with gastrotomy; LWR-C = 
laparoscopic wedge resection without gastrotomy.
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was applied via gastrotomy. After laparoscopic removal of the 
endoluminal tumor, the anterior gastrotomy was closed with en-
dolinear staplers.23 For small intraluminal tumors, intraoperative 
endoscopic guidance was sometimes required.16,18
3. Statistical analysis
Clinicopathologic features, short-term outcomes, and long-
term outcomes were analyzed using the IBM SPSS statistical 
software ver. 20 (IBM Co., Armonk, NY, USA). Categorical and 
continuous variables were analyzed by the χ2 (or Fisher’s exact 
test) and Student’s t test, respectively. Survival curves were de-
picted by the Kaplan-Meier method and compared by log-rank 
test. Two-sided P-values of less than 0.05 were considered to be 
statistically significant.
Results
The clinicopathologic features are shown in Table 1. Of a 
total of 193, 26 patients (13.5%) underwent LWR-G, and 167 
patients (86.5%) underwent LWR-C. The mean age did not dif-
fer between the two groups (P=0.419). The mean body mass in-
dex was similar between the two groups (P=0.659). Mean tumor 
size and longitudinal location between the LWR-G and LWR-
C groups were comparable (P=0.696 and P=0.913, respectively). 
However, more anterior wall-located, intraluminal tumors were 
found in the LWR-G group compared to the LWR-C group 
(P=0.022 and P=0.029, respectively). A significantly larger num-
ber of tumors (n=13, 50.0%) in the LWR-G group than in the 
LWR-C group had ulcerations (P=0.021). 
Operative outcomes are shown in Table 2. All patients in-
cluded in the current study underwent complete tumor resection 
without gross spillage, tumor rupture, or microscopic margin in-
volvement. No open conversion was noted in any patients. The 
mean operation time for LWR-G was 64.0 minutes compared 
with a mean of 55.9 minutes for LWR-C (P=0.313). Resumption 
of soft diet and postoperative hospital stay did not differ between 
the two groups. No postoperative complications were noted in 
the LWR-G group, while 3 patients (1.8%) in the LWR-C group 
Table 1. Comparison of clinicopathologic features of patients who 
underwent LWR-G and LWR-C (n=193)
Characteristic LWR-G (n=26)
LWR-C 
(n=167) P-value
Age (yr) 55.3±16.8 58.1±11.4 0.419 
   <65 18 (69.2) 119 (71.3) 0.832 
   ≥65 8 (30.8) 48 (28.7)
Sex 0.466 
   Male 10 (38.5) 77 (46.1)
   Female 16 (61.5) 90 (53.9)
Body mass index (kg/m2) 24.0±2.6 24.3±3.1 0.659 
Size (mm) 36.3±23.3 37.9±18.0 0.696 
Location (longitudinal) 0.913 
   Upper 16 (61.6) 102 (61.1)
   Middle 5 (19.2) 37 (22.1)
   Lower 5 (19.2) 28 (16.8)
Location (circular) 0.022 
   Anterior wall 10 (38.5) 33 (19.7)
   Posterior wall 6 (23.1) 35 (21.0)
   Lesser curvature 8 (30.7) 39 (23.4)
   Greater curvature 2 (7.7) 60 (35.9)
Macroscopic growth pattern 0.029 
   Extraluminal 3 (11.5) 59 (35.3)
   Intraluminal 20 (77.0) 96 (57.5)
   Mixed 3 (11.5) 12 (7.2)
Ulceration 0.021 
   Yes 13 (50.0) 46 (27.5)
   No 13 (50.0) 121 (72.5)
Values are presented as mean±standard deviation or number (%). 
LWR-G = laparoscopic wedge resection with gastrotomy; LWR-C = 
laparoscopic wedge resection without gastrotomy.
Table 2. Comparison of short-term operative outcomes 
Variable LWR-G (n=26)
LWR-C 
(n=167) P-value
Open conversion 0 0
Operation time (min)  64.0±29.9 55.9±33.4 0.313
Completeness of resection
   R0 26 167
   R1 0 0
Resumption of soft diet (POD) 1.5±1.2 1.5±1.6 0.958
Hospital stay (POD) 2.6±2.1 2.7±2.1 0.748
Complication >0.999
   Yes 0 3 (1.8)
   No 26 164 (98.2)
Mortality 0 0
Values are presented as number only, mean±standard deviation, or 
number (%). LWR-G = laparoscopic wedge resection with gastrotomy; 
LWR-C = laparoscopic wedge resection without gastrotomy; POD = 
postoperative day.
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Table 3. Comparison of pathologic outcomes
Variable LWR-G (n=26)
LWR-C 
(n=167) P-value
Size (cm) 0.190
   <2 4 (15.4) 13 (7.8)
   ≥2, <5 17 (65.4) 119 (71.2)
   ≥5, ≤10 4 (15.4) 34 (20.4)
   >10 1 (3.8) 1 (0.6)
Mitotic rate (mitoses/HPFs) 0.621
   ≤5/50 23 (88.5) 133 (79.6)
   >5/50 ≤10/50 1 (3.8) 18 (10.8)
   >10/50 2 (7.7) 16 (9.6)
Resection margin
   Negative 0 0
   Positive 26 167
NIH-fletcher 0.573
   Very low 4 (15.4) 12 (7.2)
   Low 14 (53.9) 97 (58.1)
   Moderate 5 (19.2) 37(22.1)
   High 3 (11.5) 21 (12.6)
AFIP criteria 0.846
   None 4 (15.4) 23 (13.7)
   Very low 15 (57.7) 89 (53.3)
   Low 3 (11.5) 20 (12.0)
   Moderate 4 (15.4) 24 (14.4)
   High 0 11 (6.6)
TNM classification* 0.193
   Stage IA 19 (73.1) 88 (52.7)
   Stage IB 3 (11.5) 18 (10.8)
   Stage II 3 (11.5) 48 (28.7)
   Stage III 1 (3.9) 13 (7.8)
Adjuvant Imatinib use 0.667
   No 24 (92.3) 157 (94.0)
   Yes 2 (7.7) 10 (6.0)
Recurrence
   No 26 (100) 165 (98.8) >0.999
   Yes 0 2 (1.2)
Death
   No 26 (100) 164 (98.2) >0.999
   Yes 0 3 (1.8)
Values are presented as number (%) or number only. LWR-G = 
laparoscopic wedge resection with gastrotomy; LWR-C = laparoscopic 
wedge resection without gastrotomy; HPFs = high power fields; NIH 
= National Institutes of Health; AFIP = American Forces Institute of 
Pathology. *The seventh edition of the American Joint Committee on 
Cancer Staging System.
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had complications. 
Pathologic and long-term outcomes are shown in Table 3. 
There was no statistically significant difference in the mean tu-
mor size (P=0.696). When the tumor size and mitotic rate were 
stratified according to the current risk criteria of gastric GIST, 
there was no difference in proportion of the size and mitotic rate 
between the two groups (P=0.190 and P=0.621, respectively). 
Consequently, risk based on National Institutes of Health-
Fletcher, American Forces Institute of Pathology criteria, and 
TNM classification did not differ between the groups (P=0.573, 
P=0.846, and P=0.193, respectively). Adjuvant therapy with 
imatinib mesylate was administered to 2 patients (7.7%) and 10 
patients (6.0%) in the LWR-G and LWR-C groups, respectively. 
During the median follow-up period of 36 months, 2 patients in 
the LWR-C group had recurrence in the liver and in the rem-
nant stomach at 63 and 12 months after surgery, respectively. No 
patient in the LWR-G group had recurrence. The characteristics 
of the patients with recurrence are depicted in Table 4. During 
the follow-up period, 3 patients in the LWR-C group died, but 
there were no gastric GIST-related deaths. 
Discussion
In the current study, we found that peritoneal recurrence 
due to potential spillage of cancer cells may not happen during 
LWR-G for gastric GIST. In addition, ulcerative GIST treated 
with the same procedures did not increase the risk of peritoneal 
recurrence. Gastrotomy with everting/eversion methods or in-
tragastric procedures may not increase the rate of recurrence due 
to tumor spillage by luminal exposure during LWR. In addition, 
we observed that the pattern of recurrence, especially peritoneal 
recurrence, was significantly low after LWR-G or LWR-C for 
relatively small GISTs. 
GISTs are rare tumors and a distinctive histopathological 
group of intestinal neoplasms of mesenchymal origin.3 They 
comprise fewer than 3% of all gastrointestinal cancers, and the 
most frequently involved site is the stomach, followed by the 
small intestine.3,24 Complete R0 resection without lymphad-
enectomy for primary non-metastatic GIST remains the only 
curative treatment.2,6 Since the first report of LWR of a gastric 
submucosal tumor, laparoscopic resection of GIST is considered 
to be feasible and safe from both the technical and the oncologic 
point of view.6,8,17 
Although LWR for gastric GIST has demonstrated accept-
able oncologic outcomes, the current indication is limited to 
relatively small tumors due to possible rupture of the tumor 
into the peritoneal cavity during the procedure.10,11,25-28 The Eu-
ropean Society for Medical Oncology guidelines recommend 
laparoscopic gastric wedge resection for tumors less than 2 cm 
in size, while the National Comprehensive Cancer Network and 
Japanese guidelines recommend the procedure for tumors less 
than 5 cm by experienced surgeons.10,27,28 The risk of possible 
tumor cell dissemination into the peritoneal cavity can be greatly 
increased when it is performed in conjunction with more com-
plicated procedures such as those requiring transgastric or intra-
gastric approaches. Transgastric everting for intraluminal masses 
in the posterior wall of the stomach and eversion methods for 
intraluminal tumors in the anterior wall have shown satisfactory 
short-term outcomes.14,15 However, during these procedures, 
tumors can be manipulated more vigorously, and gastric luminal 
contents can be spilled out into the peritoneal cavity.17,18 Fur-
thermore, for tumors with ulcerative lesions, the potential hazard 
is expected to worsen.18 If the GIST ruptures into the peritoneal 
cavity, the recurrence rate increases by almost 100%.29 
However, we experienced only 2 cases of recurrence in 
the LWR-C group during the median follow-up period of 36 
months. The overall incidence of recurrence was 1.0% in the 
studied patients. The results were comparable to other reported 
series in the literature.25,26 Even with ulcerative lesions, which 
comprised 50% of the lesions in the LWR-G group and had 
low to intermediate risk in most cases (data not shown), we did 
not observe any recurrence during the follow-up period. The 
low incidence of recurrence in the current study might have 
been achieved by careful manipulation of the tumors to avoid 
tumor rupture and significant spillage of gastric contents into 
the peritoneal cavity. There was no intraoperative tumor rup-
ture in the current study. Second, the indications were limited to 
relatively small tumors so that only a small portion of patients 
were classified as high-risk. Finally, by using wound protectors 
to avoid direct contact of the tumors with the surgical wound 
when retrieving the specimens, the possibility of cancer cell dis-
semination to the surgical wound was minimized. In addition, 
all patients who received adjuvant imatinib treatment showed 
favorable outcomes without recurrence in the study period. 
To our knowledge, this is the first study in the literature 
to investigate the long-term outcomes of LWR-G for gastric 
GISTs compared to conventional LWR. Our study revealed 
that gastric lumen exposure during procedures, which facilitate 
Lee S, et al.
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tumor localization and resection while avoiding excessive resec-
tion of the remnant stomach to prevent functional and structural 
deformities can be safely performed even in ulcerative lesions, 
given meticulous handling of the tumors and properly indicated 
patients. However, the study has several limitations. First, the 
current study was conducted retrospectively in a single center. 
Second, long-term outcomes, especially recurrence patterns, 
could not be properly assessed because the number of high-risk 
patients was small in both groups. Therefore, the results of the 
current study should be compared to a larger number of cases to 
determine the exact impact of luminal exposure during LWR for 
ulcerative lesions in high-risk patients.
In conclusion, LWR-G did not increase overall or peritoneal 
recurrence for the selected patients. This technique might be 
safely performed even for ulcerative gastric GISTs.
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